Condition
Primary Immune Deficiency Disorder clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Primary Immune Deficiency Disorder clinical trials that are recruiting, at sites in 2 countries (most in United States (5), Switzerland (1)). By phase: Phase 2 (4), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 2Countries
Newest Primary Immune Deficiency Disorder clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Reduced intensity bone marrow transplant for immune and bone marrow disorders | Phase 2 | Baltimore, Maryland | Recruiting | Jan 18, 2020 |
| Using donor-derived T-cells to treat BK infections in patients with weakened immune systems | Phase 1/2 | San Francisco, California and 6 other locations | Recruiting | Dec 13, 2019 |
| Understanding the causes of primary immune deficiencies | — | Zurich | Recruiting | Feb 6, 2018 |
| Using EBV-specific T-cells to treat difficult Epstein-Barr virus infections | Phase 2 | Los Angeles, California and 7 other locations | Recruiting | Aug 30, 2017 |
| Using virus-specific T-cells to treat CMV infections in young patients | Phase 2 | Los Angeles, California and 8 other locations | Recruiting | Aug 30, 2017 |
| Using specialized T-cells to treat adenovirus infections in patients with immune deficiencies | Phase 2 | Los Angeles, California and 9 other locations | Recruiting | Aug 30, 2017 |
All recruiting trials (6)
-
Reduced intensity bone marrow transplant for immune and bone marrow disorders
This study is testing a gentler type of bone marrow transplant to see if it can help people with immune and bone marrow disorders recover better and live longer.
-
Using donor-derived T-cells to treat BK infections in patients with weakened immune systems
This study is testing if special immune cells made from donors can help children and young adults with weak immune systems get rid of stubborn BK infections after a stem cell transplant.
-
Understanding the causes of primary immune deficiencies
This study looks at the causes of primary immune deficiencies to see how they affect the body's ability to fight infections and inflammation, with hopes of creating better treatments for those affected.
-
Using EBV-specific T-cells to treat difficult Epstein-Barr virus infections
This study is testing a new treatment using specially made immune cells to help children and young adults who have tough Epstein-Barr virus infections after receiving organ transplants.
-
Using virus-specific T-cells to treat CMV infections in young patients
This study is testing a new treatment using special immune cells to help children and young adults with stubborn CMV infections after organ transplants when regular medicines haven’t worked.
-
Using specialized T-cells to treat adenovirus infections in patients with immune deficiencies
This study is testing whether special T-cells can help children, teens, and young adults with weak immune systems who have ongoing adenovirus infections after organ transplants.
Related topics
Quick answers
How many Primary Immune Deficiency Disorder clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (5 trials), Switzerland (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 4, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.